Simona Ingrassano

Intravaginal 6.5 mg prasterone administration in postmenopausal women with overactive bladder syndrome: A pilot study.

S. Caruso, M. G. Matarazzo, A. Cianci, 2021, European journal of obstetrics, gynecology, and reproductive biology.